Armin Lühr

Armin Lühr

Auto-generated profile, based on publicly available information

Armin Lühr

Department of Physics, TU Dortmund University, Dortmund, Germany

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2013 in Acta Oncologica
Verified
Journal Article
Closed access
NBNiels Bassler
Niels Bassler
JTJakob Toftegaard
Jakob Toftegaard
ALArmin Lühr
Armin Lühr
BSBrita Singers Sørensen
Brita Singers Sørensen
Emanuele ScifoniEmanuele Scifoni
Emanuele Scifoni
JPJørgen B. Petersen
Jørgen B. Petersen
LET-painting was suggested as a method to overcome tumour hypoxia. In vitro experiments have demonstrated a well-established relationship between the oxygen enhancement ratio (OER) and linear energy transfer (LET), where OER approaches unity for high-LET values. However, high-LET radiation also increases the risk for side effects in normal tissue. LET-painting attempts to restrict high-LET radiation to compartments that are found to be hypoxic, while applying lower LET radiation to normoxic tissues. Methods. Carbon-12 and oxygen-16 ion treatment plans with four fields and with homogeneous dose in the target volume, are applied on an oropharyngeal cancer case with an identified hypoxic entity within the tumour. The target dose is optimised to achieve a tumour control probability (TCP) of 95% when assuming a fully normoxic tissue. Using the same primary particle energy fluence needed for this plan, TCP is recalculated for three cases assuming hypoxia: first, redistributing LET to match the hypoxic structure (LET-painting). Second, plans are recalculated for varying hypoxic tumour volume in order to investigate the threshold volume where TCP can be established. Finally, a slight dose boost (5-20%) is additionally allowed in the hypoxic subvolume to assess its impact on TCP. Results. LET-painting with carbon-12 ions can only achieve tumour control for hypoxic subvolumes smaller than 0.5 cm(3). Using oxygen-16 ions, tumour control can be achieved for tumours with hypoxic subvolumes of up to 1 or 2 cm(3). Tumour control can be achieved for tumours with even larger hypoxic subvolumes, if a slight dose boost is allowed in combination with LET-painting. Conclusion. Our findings clearly indicate that a substantial increase in tumour control can be achieved when applying the LET-painting concept using oxygen-16 ions on hypoxic tumours, ideally with a slight dose boost.

1 February 2018 in Clinical and Translational Radiation Oncology
Verified
Journal Article
Open access
ALArmin Lühr
Armin Lühr
CNCläre Von Neubeck
Cläre Von Neubeck
MKMechthild Krause
Mechthild Krause
ETEsther G.C. Troost
Esther G.C. Troost

1 August 2015 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
AJAnnika Jakobi
Annika Jakobi
ABAnna Bandurska-Luque
Anna Bandurska-Luque
KSKristin Stützer
Kristin Stützer
RHRobert Haase
Robert Haase
SLSteffen Löck
Steffen Löck
CRChristian Richter
Christian Richter

1 October 2021 in Radiotherapy and Oncology
Verified
Journal Article
Open access
BSBrita Singers Sørensen
Brita Singers Sørensen
JPJoerg Pawelke
Joerg Pawelke
JBJulia Bauer
Julia Bauer
NBNeil G. Burnet
Neil G. Burnet
ADAlexandru Dasu
Alexandru Dasu
ALArmin Lühr
Armin Lühr
Clinical treatment with protons uses the concept of relative biological effectiveness (RBE) to convert the absorbed dose into an RBE-weighted dose that equals the dose for radiotherapy with photons causing the same biological effect. Currently, in proton therapy a constant RBE of 1.1 is generically used. However, empirical data indicate that the RBE is not constant, but increases at the distal edge of the proton beam. This increase in RBE is of concern, as the clinical impact is still unresolved, and clinical studies demonstrating a clinical effect of an increased RBE are emerging. Within the European Particle Therapy Network (EPTN) work package 6 on radiobiology and RBE, a workshop was held in February 2020 in Manchester with one day of discussion dedicated to the impact of proton RBE in a clinical context. Current data on RBE effects, patient outcome and modelling from experimental as well as clinical studies were presented and discussed. Furthermore, representatives from European clinical proton therapy centres, who were involved in patient treatment, laid out their current clinical practice on how to consider the risk of a variable RBE in their centres. In line with the workshop, this work considers the actual impact of RBE issues on patient care in proton therapy by reviewing preclinical data on the relation between linear energy transfer (LET) and RBE, current clinical data sets on RBE effects in patients, and applied clinical strategies to manage RBE uncertainties. A better understanding of the variability in RBE would allow development of proton treatments which are safer and more effective.

1 December 2014 in Radiotherapy and Oncology
Verified
Journal Article
Open access
TSTomas Skripcak
Tomas Skripcak
CBClaus Belka
Claus Belka
WBWalter Bosch
Walter Bosch
CBCarsten Brink
Carsten Brink
TBThomas Brunner
Thomas Brunner
MBMichael Baumann
Michael Baumann
Disconnected cancer research data management and lack of information exchange about planned and ongoing research are complicating the utilisation of internationally collected medical information for improving cancer patient care. Rapidly collecting/pooling data can accelerate translational research in radiation therapy and oncology. The exchange of study data is one of the fundamental principles behind data aggregation and data mining. The possibilities of reproducing the original study results, performing further analyses on existing research data to generate new hypotheses or developing computational models to support medical decisions (e.g. risk/benefit analysis of treatment options) represent just a fraction of the potential benefits of medical data-pooling. Distributed machine learning and knowledge exchange from federated databases can be considered as one beyond other attractive approaches for knowledge generation within "Big Data". Data interoperability between research institutions should be the major concern behind a wider collaboration. Information captured in electronic patient records (EPRs) and study case report forms (eCRFs), linked together with medical imaging and treatment planning data, are deemed to be fundamental elements for large multi-centre studies in the field of radiation therapy and oncology. To fully utilise the captured medical information, the study data have to be more than just an electronic version of a traditional (un-modifiable) paper CRF. Challenges that have to be addressed are data interoperability, utilisation of standards, data quality and privacy concerns, data ownership, rights to publish, data pooling architecture and storage. This paper discusses a framework for conceptual packages of ideas focused on a strategic development for international research data exchange in the field of radiation therapy and oncology.

23 November 2022 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
JEJan Eulitz
Jan Eulitz
ETEsther G. C. Troost
Esther G. C. Troost
LKLauritz Klünder
Lauritz Klünder
FRFelix Raschke
Felix Raschke
CHChristian Hahn
Christian Hahn
ALArmin Lühr
Armin Lühr